Stock Message Board http://investorshangout.com/search?q=AMPE&...mp;yt1=Go!
Last Updated: Saturday, January 11, 2014 10:43:01 PM
Ampio Pharmaceuticals, Inc. AMPE Current Price and Quotes
Last Price 9.35
Previous Close 8.12 Open 8.20
Daily Range 9.80 - 8.12 52wk Range 10.86 - 3.60
Volume 1,679,485 Dividend N/A
Average Vol (3m) 382,924 Yield N/A
Ampio Pharmaceuticals, Inc. AMPE
Company Information
5445 DTC Parkway, P4
Greenwood Village, CO 80111
Website: http://www.ampiopharma.com
Phone: 303-418-1000
Ampio Pharmaceuticals, Inc. AMPE
Ampio Pharmaceuticals, Inc. develops innovative proprietary drugs for metabolic disease, eye disease, kidney disease, inflammation and CNS disease. The product pipeline includes new uses for previously approved drugs, some of which are now starting clinical trials, and new molecular entities ("NMEs"). A key strategy includes actively exploring partnership, licensing and other collaboration opportunities to maximize the company's product development programs.
Ampio Pharmaceuticals, Inc. AMPE
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Latest Report Sep 30, 2013 10-Q
CIK 0001411906
Fiscal Year End 12/31
OTC Marketplace Not Available
Profile Data
SIC - Industry Classification Not Available
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Notes
Formerly=Chay Enterprises, Inc. until 3-2010
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Redwood Consultants, LLC
250 Bel Marin Keys Bldg.
Novato, CA, 94949
United States
Ampio Pharmaceuticals, Inc. AMPE
AMPE Security Details
Share Structure
Market Value1 $346,851,995 a/o Jan 10, 2014
Shares Outstanding 41,789,397 a/o Nov 08, 2013
Float 3,256,587 a/o Apr 26, 2011
Authorized Shares 100,000,000 a/o Dec 31, 2010
Par Value No Par Value
Shareholders
Shareholders of Record 250 a/o Feb 16, 2011
Security Notes
Capital Change=shs decreased by 1 for 3.5 split. Pay date=08/01/2008.
Short Selling Data
Short Interest 0 (-100%)
May 31, 2011
Significant Failures to Deliver No
Transfer Agent(s)
Ampio Pharmaceuticals, Inc. AMPE Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 50 19 - -
Cost of Revenue - - - -
Gross Profit 50 19 - -
Operating Expenses
Research and Development 7,494 6,648 1,972 1,070
Sales, General and Admin. 4,377 4,504 4,732 441
Non-Recurring Items - - - -
Other - - - -
Operating Income (11,821) (11,134) (6,704) (1,512)
Income From Continuing Operations
Add'l Income/Expense Items 228 (7,134) (1,329) 1
Earnings Before Interest and Tax (11,593) (18,268) (8,034) (1,510)
Interest Expense - 8 20 1
Earnings Before Tax (11,593) (18,277) (8,053) (1,512)
Income Tax - 83 - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (11,593) (18,359) (8,053) (1,512)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (11,593) (18,359) (8,053) (1,512)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (11,593) (18,359) (8,053) (1,512)
Ampio Pharmaceuticals, Inc. AMPE Recent News
Jan 9, 2014 Luoxis Awarded ISO 13485:2003 and ISO 9001:2008 Certifications
Jan 6, 2014 Luoxis Establishes Study Collaborations with Two Research Centers in Oxidative Stress
Dec 16, 2013 Ampio Pharmaceuticals Leases New Facility in Denver Tech Center
Dec 13, 2013 Ampio Pharmaceuticals Spins-Off Sexual Dysfunction Business
Dec 3, 2013 Two Prominent Scientists Join Ampio Pharmaceuticals Scientific Advisory Board (SAB)
Dec 2, 2013 Ampio Receives FDA Confirmation that The Spring Study is Pivotal and Will Initiate the Final Pivotal Trial for Ampion(TM) Biological License Application (BLA)
Nov 19, 2013 Ampio Responds to Levi & Korsinsky, LLP Press release/solicitation
Nov 18, 2013 AMPIO PHARMACEUTICALS, INC. SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Ampio Pharmaceuticals, Inc.
Nov 15, 2013 Ampio Pharmaceuticals to Present at Upcoming Investor Conference
Nov 4, 2013 Ampio Pharmaceuticals Reports Positive Results in the Extended Spring study of Osteoarthritis of the Knee Following a Single Intra-articular Injection of Ampion(TM)
1
2
next >
AMPE Ampio Pharmaceuticals, Inc. Research DD Guide
Stock Message Board http://investorshangout.com/search?q=AMPE&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/AMPE/quote
Stock Chart http://www.otcmarkets.com/stock/AMPE/chart
Company Info http://www.otcmarkets.com/stock/AMPE/company-info
Recent News http://www.otcmarkets.com/stock/AMPE/news
Financials http://www.otcmarkets.com/stock/AMPE/financials
Filings and Disclosure http://www.otcmarkets.com/stock/AMPE/filings
Short Sales http://www.otcmarkets.com/stock/AMPE/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/AMPE/insider-transactions
Research Reports http://www.otcmarkets.com/stock/AMPE/research
Summary http://finance.yahoo.com/q?s=AMPE
Historical Prices http://finance.yahoo.com/q/hp?s=AMPE+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=AMPE
Basic Chart http://finance.yahoo.com/q/bc?s=AMPE+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=AMPE+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=AMPE+Headlines
Press Releases http://finance.yahoo.com/q/p?s=AMPE+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=AMPE+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=AMPE+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=AMPE+Industry
Major Holders http://finance.yahoo.com/q/mh?s=AMPE+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=AMPE+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=AMPE+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=AMPE
Balance Sheet http://finance.yahoo.com/q/bs?s=AMPE
Cash Flow http://finance.yahoo.com/q/cf?s=AMPE+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/AMPE
Market Watch http://www.marketwatch.com/investing/stock/AMPE
Bloomberg http://www.bloomberg.com/quote/AMPE:US
Morningstar http://quotes.morningstar.com/stock/s?t=AMPE
Bussinessweek http://investing.businessweek.com/research/st...icker=AMPE
Barchart http://www.barchart.com/quotes/stocks/AMPE
OTC Short Report http://otcshortreport.com/index.php?index=AMPE
Investopedia http://www.investopedia.com/markets/stocks/AMPE/?wa=0